healthprotocol.wiki
Protocols
Evidence
Outcomes
Home
/
Outcomes
safety-grade-3-or-higher-adverse-events-cohort-measured
1 evidence row · 1 protocol
Evidence
capitello-281_0000_rct_capitello-281-a-phase-3-study-of-capivasertib-abiraterone-vs-placebo-abiraterone-in-patients-with-pten-deficient-de-novo-metastatic-hormone-sensitive-prostate-cancer
Protocols
medication-cancer-prostate-capivasertib-abiraterone-androgen-deprivation
healthprotocol.wiki